These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics. Debrabant A; Joshi MB; Pimenta PF; Dwyer DM Int J Parasitol; 2004 Feb; 34(2):205-17. PubMed ID: 15037106 [TBL] [Abstract][Full Text] [Related]
28. A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers. Hart DT; Vickerman K; Coombs GH Parasitology; 1981 Jun; 82(Pt 3):345-55. PubMed ID: 7243344 [TBL] [Abstract][Full Text] [Related]
29. In vivo assay of viability of amastigotes of Leishmania donovani. Hodgkinson VH; Herman R J Parasitol; 1980 Apr; 66(2):245-9. PubMed ID: 7391863 [TBL] [Abstract][Full Text] [Related]
30. Determination of virulence and pathogenesis of a canine strain of Leishmania leishmania infantum in hamsters and dogs. Binhazim AA; Chapman WL; Shin SS; Hanson WL Am J Vet Res; 1993 Jan; 54(1):113-21. PubMed ID: 8427454 [TBL] [Abstract][Full Text] [Related]
31. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening. Singh N; Gupta R; Jaiswal AK; Sundar S; Dube A J Antimicrob Chemother; 2009 Aug; 64(2):370-4. PubMed ID: 19525291 [TBL] [Abstract][Full Text] [Related]
32. A simple method for maintaining, detecting and recovering virulent Leishmania donovani in hamsters. Anjili CO; Mbati PA; Mwangi RW; Githure JI; Koech DK Acta Trop; 1996 Feb; 60(4):263-7. PubMed ID: 8659325 [TBL] [Abstract][Full Text] [Related]
33. The interaction of Leishmania donovani promastigotes and human fibroblasts in vitro. Schwartzman JD; Pearson RD Am J Trop Med Hyg; 1985 Sep; 34(5):850-5. PubMed ID: 4037177 [TBL] [Abstract][Full Text] [Related]
34. A study of the sensitivity of Leishmania donovani promastigotes and amastigotes to hydrogen peroxide. I. Differences in sensitivity correlate with parasite-mediated removal of hydrogen peroxide. Channon JY; Blackwell JM Parasitology; 1985 Oct; 91 ( Pt 2)():197-206. PubMed ID: 4069751 [TBL] [Abstract][Full Text] [Related]
35. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages. Prina E; Lang T; Glaichenhaus N; Antoine JC J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803 [TBL] [Abstract][Full Text] [Related]
36. Cutaneous lesions in hamsters caused by Leishmania donovani promastigotes derived from axenic amastigotes. Anjili CO; Mbati PA; Lugalia RM East Afr Med J; 1995 Jul; 72(7):476. PubMed ID: 7498035 [No Abstract] [Full Text] [Related]
37. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis. Samant M; Gupta R; Kumari S; Misra P; Khare P; Kushawaha PK; Sahasrabuddhe AA; Dube A J Immunol; 2009 Jul; 183(1):470-9. PubMed ID: 19542458 [TBL] [Abstract][Full Text] [Related]
38. Leishmania donovani: amastigote inhibition and mode of action of berberine. Ghosh AK; Bhattacharyya FK; Ghosh DK Exp Parasitol; 1985 Dec; 60(3):404-13. PubMed ID: 4076392 [TBL] [Abstract][Full Text] [Related]
39. Comparison of two geographic strains of Leishmania donovani by resistance of mice to superinfection. Holbrook TW; Palczuk NC Am J Trop Med Hyg; 1975 Jul; 24(4):704-6. PubMed ID: 125553 [TBL] [Abstract][Full Text] [Related]